Skip to Content

Qudexy XR Approval History

Qudexy XR (topiramate) is an antiepileptic drug indicated for the treatment of partial onset seizures, primary generalized tonic-clonic seizures, and Lennox-Gastaut Syndrome.

FDA Approval History for Qudexy XR

Jun  1, 2015Approval FDA Approves Expanded Indication for Qudexy XR (Topiramate) for Pediatric Patients
Mar 12, 2014Approval Upsher-Smith Receives FDA Approval for Qudexy XR (topiramate) Extended-Release Capsules

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.